共 31 条
[3]
FDA drug approval summary:: Erlotinib (Tarceva®) tablets
[J].
ONCOLOGIST,
2005, 10 (07)
:461-466
[7]
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non-Small-Cell Lung Cancer in Asia (IPASS)
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2011, 29 (21)
:2866-2874